Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-05-27 09:22 am Purchase | 2022-05-26 | 13G | Qualigen Therapeutics, Inc. QLGN | ALPHA CAPITAL ANSTALT | 7,050 9.990% | 4,570 (+184.26%) | Filing History |
| 2022-01-04 9:08 pm Sale | 2021-12-31 | 13G | Qualigen Therapeutics, Inc. QLGN | SABBY MANAGEMENT LLC | 0 0.000% | -3,920 (Position Closed) | Filing History |
| 2021-12-06 5:04 pm Purchase | 2021-11-29 | 13G | Qualigen Therapeutics, Inc. QLGN | SABBY MANAGEMENT LLC | 3,920 11.000% | 3,920 (New Position) | Filing History |
| 2020-06-01 5:00 pm Purchase | 2020-05-22 | 13G | Qualigen Therapeutics, Inc. QLGN | SEKISUI DIAGNOSTICS LLC | 3,960 15.800% | 3,960 (New Position) | Filing History |
| 2020-06-01 4:46 pm Purchase | 2020-05-22 | 13G | Qualigen Therapeutics, Inc. QLGN | Greenblock Capital LLC | 1,623 6.500% | 1,623 (New Position) | Filing History |
| 2020-05-28 4:05 pm Purchase | 2020-05-22 | 13G | Qualigen Therapeutics, Inc. QLGN | ALPHA CAPITAL ANSTALT | 2,480 9.900% | 2,480 (New Position) | Filing History |
| 2020-02-14 09:56 am Sale | 2019-12-31 | 13G | RITTER PHARMACEUTICALS INC RTTR | Alyeska Investment Group L.P. | 425,000 4.200% | -147,890 (-25.81%) | Filing History |